Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study.
about
Hepatitis B vaccination during pregnancy for preventing infant infectionHepatitis B vaccination during pregnancy for preventing infant infectionKASL clinical practice guidelines: management of chronic hepatitis BManagement of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelinesManagement of chronic hepatitis B in pregnancyHepatitis B Management in the Pregnant Patient: An UpdateA Review of Antiviral Use for the Treatment of Chronic Hepatitis B Virus Infection in Pregnant Women.Impact of maternal hepatitis B virus coinfection on mother-to-child transmission of HIVHepatitis B surface antigenemia (HBsAg) among pregnant women in southern Nigeria.Vertical transmission of hepatitis B virus: challenges and solutionsHepatitis B and hepatitis C seroprevalence in children receiving antiretroviral therapy for human immunodeficiency virus-1 infection in China, 2005-2009.Evaluation of the patient with hepatitis BHepatitis B Virus Infection during Pregnancy: Transmission and Prevention.Hepatitis B Therapy in PregnancyIndividualized management of pregnant women with high hepatitis B virus DNA levels.Evaluation and management of hepatitis B in pregnancy: a survey of current practicesSafety of tenofovir during pregnancy for the mother and fetus: a systematic review.2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.The effects of telbivudine in late pregnancy to prevent intrauterine transmission of the hepatitis B virus: a systematic review and meta-analysis.Missed opportunities for prevention of perinatal transmission of hepatitis B: a retrospective cohort study.Breastfeeding is not a risk factor for mother-to-child transmission of hepatitis B virus.Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice.Tenofovir rescue therapy in pregnant females with chronic hepatitis BPrevention of hepatitis B.Hepatitis B e antigen status and hepatitis B DNA levels in women of childbearing age with chronic hepatitis B infection screening for clinical trials.A nested case-control study of maternal-neonatal transmission of hepatitis B virus in a Chinese population.The role of co-infections in mother-to-child transmission of HIV.A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virusModels for predicting hepatitis B e antigen seroconversion in response to interferon-α in chronic hepatitis B patientsChronic hepatitis B infection in pregnancyManagement of chronic hepatitis B in patients from special populationsHIV-HBV coinfection--a global challengeChronic hepatitis B in pregnancy: unique challenges and opportunitiesManagement of hepatitis B during pregnancy.Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis.Epidemiology of Hepatitis B Virus Infection in China: Current Status and ChallengesOptimal Management of the Hepatitis B Patient Who Desires Pregnancy or Is PregnantKASL Clinical Practice Guidelines: Management of chronic hepatitis B.24 year outcomes of hepatitis B vaccination in Hangzhou, China.Cost-effectiveness of testing hepatitis B-positive pregnant women for hepatitis B e antigen or viral load
P2860
Q24188025-77234319-C804-44A3-908A-5BA27D0E10B0Q24235783-72696E52-B838-4AFD-B60A-615FEBAD0C44Q26752475-1B49B90D-8EAB-4D45-AEE0-C488E8280A08Q27000080-3BD7EB15-E84D-43AB-9340-A6C58E03D210Q27026593-DBFFD186-FFB5-43C8-AA2E-0CD4A2450E8BQ28066219-A74433B6-724C-49CA-8E61-8D50DB7CB8C0Q33711399-76E733E0-73B3-4595-ACF4-4E500145A4E2Q33748047-22F4A972-4715-4BF0-8B58-C453B09E4EEAQ33751625-4BA4EA96-9BE0-46C5-BA08-5342E9F2F689Q33774099-C22BCB59-F079-477F-9625-590D14876E54Q33882122-D2F3E807-639C-4754-8D15-80B7C98AE380Q33896660-1D6913FC-011F-492A-BDB1-A646048A568BQ34135030-4D7352EA-E176-4A80-B422-6CA1CAEB2C6BQ34154952-2172E8C8-6F43-4A97-B2F1-E07EFEAD1725Q34168470-22A388FA-B600-4791-A61B-8E4FA070B976Q34293333-9AB5724E-1AC0-4D37-9C28-29403F7EF19CQ34371989-E1E03BEB-F5B3-40F9-968D-EF271F03AFFAQ34390072-BA2DA34D-7FBC-4381-A6CC-A512BABEAB79Q34402956-82242139-45E5-48AE-8F6F-EB6B26B72832Q34524575-D1CA5A95-485C-4197-A6C1-24FC62ED79C7Q34576359-C42D04AC-1F71-4EC5-B2E7-884B40E37B3DQ34805931-BE195711-FD70-4C9E-9CE1-5C86BBF161E0Q35128259-CF2B375F-5F2F-4296-9817-9937BDB6468CQ35164249-43E02DDF-130A-4313-86E2-A69D57162E96Q35196581-3B5D9CA3-016D-48D9-8DEC-7D27E025C1E4Q35232208-63222E9F-7874-4662-9E92-01652128DAB5Q35542406-E089B74C-B48B-4304-B425-82952CD2A01BQ35545742-F9E60386-6E50-47F8-BEAC-726204AAF3FEQ35594289-2EAF03D7-DC82-4418-887B-E0488D4357F7Q35626775-1FB68C57-EE93-4EB9-8BD4-35E3014302A1Q35664183-BFE150D5-636E-4074-8FEB-19F870EB990FQ35678473-EB13C240-B216-458D-9FC8-3796648E6038Q35833069-9146C639-A326-4214-A165-C63EE55BD109Q35838778-A4561441-BAFC-4D41-BEC8-43F599CEDF56Q35840548-EF8D4055-DD78-4766-90D2-78A2C76F9167Q35905968-DFF1FD31-1371-4023-8F31-9552825DBE7CQ35999165-E83CF138-DF00-4A56-893E-6E1344362D94Q36153966-8598353F-C2BA-402E-9B3A-A31F9E74DB5DQ36256369-61E5B656-F655-45B1-ABD4-35F006D2568FQ36379986-9C4C1D3C-76D8-4DFF-8CBC-E18FA8859065
P2860
Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Lamivudine in late pregnancy t ...... ind, placebo-controlled study.
@en
Lamivudine in late pregnancy t ...... ind, placebo-controlled study.
@nl
type
label
Lamivudine in late pregnancy t ...... ind, placebo-controlled study.
@en
Lamivudine in late pregnancy t ...... ind, placebo-controlled study.
@nl
prefLabel
Lamivudine in late pregnancy t ...... ind, placebo-controlled study.
@en
Lamivudine in late pregnancy t ...... ind, placebo-controlled study.
@nl
P2093
P2860
P1476
Lamivudine in late pregnancy t ...... lind, placebo-controlled study
@en
P2093
F Campbell
P2860
P304
P356
10.1111/J.1365-2893.2008.01056.X
P577
2008-10-08T00:00:00Z